Table 2.
Male, p < 0.001 |
Female, p < 0.001 |
All, p < 0.001 |
||||
---|---|---|---|---|---|---|
HR (95 % CI) | p value | HR (95 % CI) | p value | HR (95 % CI) | p value | |
Septal Thickness | 1.04 (1.01–1.06) | 0.002 | 1.05 (1.02–1.08) | < 0.001 | 1.04 (1.02–1.06) | < 0.001 |
Age | 1.057 (1.054–1.059) | < 0.001 | 1.053 (1.05–1.055) | < 0.001 | 1.055 (1.053–1.057) | < 0.001 |
Hypertension | 1.12 (1.06–1.19) | < 0.001 | 1.12 (1.05–1.19) | < 0.001 | 1.12 (1.07–1.16) | < 0.001 |
Dyslipidaemia | 0.83 (0.19–0.89) | < 0.001 | 0.94 (0.87–0.98) | 0.007 | 0.87 (0.84–0.91) | < 0.001 |
Diabetes | 1.57 (1.48–1.66) | < 0.001 | 1.49 (1.4–1.59) | < 0.001 | 1.54 (1.47–1.6) | < 0.001 |
IHD | 0.92 (0.86–0.97) | 0.003 | 1.07 (0.99–1.15) | 0.08 | 0.97 (0.93–1.02) | 0.26 |
Atrial fibrillation | 1.1 (1.03–1.18) | 0.006 | 1.05 (0.97–1.12) | 0.2 | 1.07 (1.02–1.13) | 0.05 |
CHF | 1.5 (1.34–1.62) | < 0.001 | 1.58 (1.45–1.7) | < 0.001 | 1.54 (1.46–1.62) | < 0.001 |
LVM /BSA | 0.996 (0.995–0.998) | < 0.001 | 0.998 (0.996–1) | 0.11 | 0.998 (0.996–0.999) | 0.003 |
LVEDd /BSA | 1.02 (1––1.03) | 0.05 | 0.97 (0.96–0.99) | 0.005 | 0.99 (0.98–1) | 1.43 |
LVESd /BSA | 1.02 (1–1.03) | 0.004 | 1.02 (1–1.03) | 0.006 | 1.02 (1.01–1.03) | < 0.001 |
Ejection fraction | 0.99 (0.98–1) | < 0.001 | 0.98 (0.97–0.99) | < 0.001 | 0.99 (0.985–0.991) | < 0.001 |
LA volume /BSA | 1.006 (1.004–1008) | < 0.001 | 1.008 (1.006–1) | < 0.001 | 1.007 (1.006–1.008) | < 0.001 |
AS ≥ moderate | 0.98 (0.88–1.09) | 0.77 | 1.09 (0.99–1.2) | 0.07 | 1.04 (0.97–1.12) | 0.27 |
MR ≥ moderate | 0.96 (0.85–1.07) | 0.45 | 1.13 (1.01–1.27) | 0.03 | 1.05 (0.97–1.13) | 0.27 |
HR, hazard ratio; CI, confidence interval; IHD, ischaemic heart disease; CHF, congestive heart failure;
LVM, left ventricular mass; BSA, body surface area; LVEDd, left ventricular end diastolic diameter; LVESd, left ventricular end systolic diameter; LA, left atrium; AS, aortic stenosis; MR, mitral regurgitation;